| |
| |
|
| Insider
Information: |
Rothblatt Martine A |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
130 |
|
|
Indirect Shares
|
647,065 |
|
|
| Direct
Value |
$35,937 |
|
|
|
Indirect Value
|
$178,874,649 |
|
|
| Total
Shares |
647,195 |
|
|
| Total
Value |
$178,910,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
|
2024-05-21 |
130 |
2024-05-21 |
647,065 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
2036 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 59 of 82
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-14 |
4 |
OE |
$30.75 |
$28,259 |
I/I |
919 |
673,418 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-14 |
4 |
AS |
$121.85 |
$153,575 |
D/D |
(1,258) |
1,069 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-21 |
4 |
OE |
$30.75 |
$39,176 |
D/D |
1,274 |
2,343 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-21 |
4 |
OE |
$30.75 |
$27,737 |
I/I |
902 |
674,320 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-21 |
4 |
AS |
$115.83 |
$147,868 |
D/D |
(1,274) |
1,069 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-28 |
4 |
OE |
$30.75 |
$38,899 |
D/D |
1,265 |
2,334 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-28 |
4 |
OE |
$30.75 |
$28,044 |
I/I |
912 |
675,232 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-09-28 |
4 |
AS |
$119.44 |
$151,416 |
D/D |
(1,265) |
1,069 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-05 |
4 |
OE |
$30.75 |
$38,622 |
D/D |
1,256 |
2,325 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-05 |
4 |
OE |
$30.75 |
$28,290 |
I/I |
920 |
676,152 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-05 |
4 |
AS |
$121.94 |
$154,459 |
D/D |
(1,256) |
1,069 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-12 |
4 |
OE |
$30.75 |
$38,837 |
D/D |
1,263 |
2,332 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-12 |
4 |
AS |
$120.20 |
$151,813 |
D/D |
(1,263) |
1,069 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-12 |
4 |
OE |
$30.75 |
$28,106 |
I/I |
914 |
677,066 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-19 |
4 |
OE |
$30.75 |
$38,899 |
D/D |
1,265 |
1,405 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-19 |
4 |
OE |
$30.75 |
$28,013 |
I/I |
911 |
677,977 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-19 |
4 |
AS |
$118.91 |
$151,014 |
D/D |
(1,265) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-26 |
4 |
OE |
$30.75 |
$38,837 |
D/D |
1,263 |
1,403 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-26 |
4 |
OE |
$30.75 |
$28,106 |
I/I |
914 |
678,891 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-10-26 |
4 |
AS |
$120.13 |
$152,037 |
D/D |
(1,263) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-11-02 |
4 |
OE |
$30.75 |
$39,022 |
D/D |
1,269 |
1,409 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-11-02 |
4 |
OE |
$30.75 |
$27,890 |
I/I |
907 |
679,798 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-11-02 |
4 |
AS |
$117.78 |
$149,795 |
D/D |
(1,269) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-11-09 |
4 |
OE |
$30.75 |
$38,745 |
D/D |
1,260 |
1,400 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & CEO |
• • – |
2017-11-09 |
4 |
OE |
$30.75 |
$28,198 |
I/I |
917 |
680,715 |
0 |
- |
|
2036 Records found
|
|
Page 59 of 82 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
